All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
JASPER THERAPEUTICS, INC. Last Reported: 1/31/2024 Stock Symbol: JSPRW

Business Address

2200 BRIDGE PKWY SUITE #102

REDWOOD CITY , CA US 94065

Mailing Address

2200 BRIDGE PKWY SUITE #102

REDWOOD CITY , CA US 94065
Phone Number: 650-549-1400 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 9/30/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 8/31/2019
Cash and Cash Equivalents $103,867,000.00 $115,800,000.00 $129,400,000.00 $50,950,000.00 $60,814,000.00 $70,400,000.00 $100,905,000.00 $309,730.00 $770,114.00 $757,523.00 $914,249.00 $1,057,195.00 $1,212,755.00 -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $1,351,000.00 $2,755,000.00 $3,108,000.00 $1,461,000.00 $2,472,000.00 $3,399,000.00 $1,502,000.00 -- -- -- -- -- -- -- --
Total Current Assets $105,218,000.00 $118,567,000.00 $132,508,000.00 $52,411,000.00 $63,286,000.00 $73,799,000.00 $102,407,000.00 $422,927.00 $921,642.00 $963,509.00 $1,181,331.00 $1,389,466.00 $1,539,063.00 -- --
Property Plant and Equipement $2,780,000.00 $3,056,000.00 $3,320,000.00 $3,759,000.00 $4,016,000.00 $3,499,000.00 $3,278,000.00 -- -- -- -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $411,000.00 $445,000.00 $725,000.00 $543,000.00 $577,000.00 $611,000.00 -- -- -- -- -- -- -- -- --
Total Assets $110,405,000.00 $124,170,000.00 $138,757,000.00 $59,110,000.00 $70,366,000.00 $80,548,000.00 $107,213,000.00 $100,549,035.00 $101,261,021.00 $101,318,228.00 $101,597,344.00 $101,792,076.00 $101,693,635.00 -- --
Accounts Payable $3,256,000.00 $1,581,000.00 $3,846,000.00 $3,117,000.00 $2,997,000.00 $1,466,000.00 $2,247,000.00 -- -- -- -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- $2,500,000.00 -- -- -- -- -- -- -- --
Total Current Liabilities $16,272,000.00 $13,965,000.00 $13,559,000.00 $11,545,000.00 $11,585,000.00 $12,443,000.00 $28,611,000.00 $14,258,928.00 $3,769,451.00 $3,680,348.00 $3,758,273.00 $3,670,946.00 $3,611,364.00 -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Accumulated Deficit $-153,019,000.00 $-135,475,000.00 $-119,395,000.00 $-91,924,000.00 $-80,061,000.00 $-69,657,000.00 $-58,393,000.00 $-5,148,544.00 $-588,658.00 $-442,348.00 $-241,157.00 $40,902.00 $2,043.00 -- --
Total Stockholders' Equity $94,133,000.00 $110,205,000.00 $125,198,000.00 $47,565,000.00 $58,781,000.00 $68,105,000.00 $78,602,000.00 $5,000,007.00 $5,000,010.00 $5,000,010.00 $5,000,001.00 $5,000,010.00 $5,000,001.00 $24,000.00 --
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $110,405,000.00 $124,170,000.00 $138,757,000.00 $59,110,000.00 $70,366,000.00 $80,548,000.00 $107,213,000.00 $100,549,035.00 $101,261,021.00 $101,318,228.00 $101,597,344.00 -- $101,693,635.00 -- --

Statement of Operations

Date 9/30/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 3/31/2022 9/30/2021 6/30/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 8/31/2019
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $14,848,000.00 $13,297,000.00 $9,805,000.00 $9,022,000.00 $8,135,000.00 $8,188,000.00 $16,764,000.00 -- -- -- -- -- -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $51,136,000.00 $17,827,000.00 $13,947,000.00 $12,708,000.00 $24,741,000.00 $12,778,000.00 $10,079,000.00 -- -- -- -- -- -- -- --
Loss from Operations $-51,136,000.00 $-31,774,000.00 $-13,947,000.00 $-37,449,000.00 $-24,741,000.00 $-12,778,000.00 $-24,751,000.00 $-776,434.00 $-935,400.00 $-220,289.00 $-327,561.00 $-228,666.00 $-136,304.00 -- $-1,000.00
Loss Before Income Taxes -- -- -- -- -- -- -- $1,928,537.00 $-552,250.00 $-370,613.00 $-283,254.00 $96,682.00 $18,268.00 -- $-1,000.00
Earnings Per Share Basic $-0.47 $-0.31 $-0.16 $-0.32 -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 109,720,741 109,213,669 88,159,248 36,565,650 -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.16 $-0.31 $-0.16 $-0.67 -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 102,351,140 98,605,265 88,159,248 36,425,000 -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 492,000,000 492,000,000 492,000,000 492,000,000 492,000,000 492,000,000 492,000,000 -- -- -- -- -- -- -- --
Common Stock Shares Outstanding 110,850,413 110,800,413 109,428,211 37,984,368 37,981,317 37,874,207 37,816,310 -- -- 736,213 -- -- 691,773 -- --
Common Stock Value $11,000.00 $11,000.00 $11,000.00 $4,000.00 $4,000.00 $4,000.00 $4,000.00 $187.00 -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- --
Share Price $0.70 -- -- -- -- -- -- $9.94 -- -- -- -- -- -- --
Copyright 2024 PursePoor.com